Introduction
Control of gene expression by microRNAs (miRNAs) has recently emerged as a key mechanism that regulates multiple aspects of immune homeostasis, from cell fate determination during hematopoiesis to fine-tuning of immune response to infection. 1, 2 Support for this notion was first provided by studies that investigated the consequences of global abrogation of miRNA processing in B and T lymphocytes.
Conditional deletion of Dicer, which encodes an endonuclease required for miRNA biogenesis, in CD19 1 B cells drastically alters differentiation of peripheral B-cell subsets and results in expansion of marginal zone (MZ) B cells at the expense of follicular (FO) B cells. 3 Moreover, germinal center (GC) formation, generation of long-lived plasma cells, and production of high-affinity class-switched antibodies in response to antigen challenge are impaired in mice with specific Dicer ablation in activated B cells. 4 miRNA control is also indispensible for T-lymphocyte homeostasis and function, as T-cell-specific Dicer knockout (KO) mice display smaller peripheral T-cell compartments, as well as defective proliferation and cytokine production by helper T cells. 5 Although the above-mentioned studies using global ablation of miRNA expression have clearly established an essential role for miRNAs in hematopoiesis and immunity, the challenge today is to determine the contribution of individual miRNA genes to the regulation of immunologic processes and to define the molecular mechanism by which they elicit this control.
miR-142 is one of a few miRNA genes that are preferentially expressed in cells of hematopoietic origin. [6] [7] [8] It encodes 2 mature miRNA molecules (miR-142-3p and miR-142-5p) that are derived from opposite strands of a hairpin-like precursor. Both miRNAs are evolutionarily conserved and found in vertebrate genomes from fish to humans.
The biological role of miR-142 remains poorly understood. Knockdown of miR-142-3p expression in zebrafish revealed a critical role for this miRNA in hematopoiesis during embryonic development, hematopoietic stem cell homeostasis, neutrophil differentiation, and heart development. [9] [10] [11] In mice, miR-142 is essential for normal development and function of megakaryocytes, dendritic, and mast cells.
Methods
See supplemental Methods (available at the Blood Web site) for additional methods.
Generation of miR-142
2/2 mice miR-142 null mice were generated by deleting ;900 bp of genomic sequence that encompasses the miR-142 precursor (supplemental Figure 1A) . A targeting vector containing 2 LoxP sites, a neomycin-positive selection cassette flanked by FRT sites, and a diphtheria toxin A-negative selection cassette was electroporated into C57BL/6J embryonic stem (ES) cells. The targeted ES cells were microinjected into host C57BL/6J-Tyr c-2J
/J blastocysts and implanted into pseudopregnant foster mothers to produce chimeric mice. The resulting chimeras were bred with C57BL/6J mice to obtain offspring with the targeted miR-142 locus in the germline (F1 generation). F1 mice were crossed with a Cre-deleter strain (C57BL/6Tg(EIIa-Cre)) to remove the miR-142 locus and the neomycin cassette. The resulting miR-142 1/2 animals were interbred to produce the miR-142 2/2 line. All experimental procedures described in this study used C57BL/ 6J mice (obtained from The Jackson Laboratory and denoted hereafter as wild-type [WT]) for controls. All animal experiments were approved by the Institutional Animal Care and Use Committee of the City of Hope.
Bone marrow adoptive transfer
To perform competitive bone marrow (BM) reconstitution assays, 3 3 10 Global gene expression profiling using DNA microarrays B cells from 6-week-old WT and miR-142 KO males (n 5 3 per genome) were purified from single-cell suspensions of splenocytes using anti-mouse CD19 magnetic beads (Miltenyi Biotec) according to manufacturer's protocol. Total RNA was isolated using a miRNeasy kit (QIAGEN) and subjected to analysis on a GeneChip Mouse Genome 430A 2.0 Array (Affymetrix). Differential analysis of gene expression in WT and miR-142 KO cells was performed using Partek's Genomics Suite software. Analysis of enrichment of miR-142-3p and miR-142-5p seed sequences in expression profiles was performed by the Web-based SylArray software algorithm (http://www.ebi.ac.uk/enright-srv/sylarray/). DNA microarray and sample annotation data were deposited in the Gene Expression Omnibus under the accession number GSE61919.
Results
Immunoproliferative disorder in miR-142 2/2 mice
To test experimentally the physiological role of miR-142, we generated a mouse line with a targeted deletion of this miRNA gene (supplemental Figure 1A -B). As predicted, miR-142 2/2 mice display virtually no expression of both mature miR-142-3p and miR-142-5p in immune cells (supplemental Figure 1C) . miR-142 2/2 mice are born at the expected Mendelian ratios and appear healthy and fertile. Gross morphologic analysis of miR-142
animals at necropsy did not reveal any apparent internal organ defects, except for significant enlargement of the spleen ( Figure 1A -B). Splenomegaly was highly penetrant in miR-142 2/2 mice but was not accompanied by concurrent lymphadenopathy. Spleen enlargement was characterized by a marked increase in organ cellularity ( Figure 1C ), suggesting that miR-142 deletion results in an immunoproliferative disorder. Analysis of miR-142 2/2 splenocytes by flow cytometry revealed a significant expansion of both B-cell and myeloid cell populations ( Figure 1D -G). The number of CD19
in the KO spleen increased ;2.5 times in comparison to the WT control ( Figure 1E ). 15 We observed that the peritoneal cavities of the KO mice were virtually devoid of CD19 
B220
lo lymphocytes (Figure 2A-B) , a cellular population that is typically defined as B1 B cells. 16 Subsequent analysis of miR-142
peritoneal cavity lymphocytes using immunoglobulin M (IgM), CD11b, and CD5 markers further confirmed a marked contraction of the B1 B-cell population (supplemental Figure 2A-B) . Deletion of miR-142 diminished production of both CD5 1 B1a and CD5 2 B1b
B cells, with a greater effect observed in the B1a subset (supplemental Figure 2A-B) .
In the spleen, miR-142 2/2 B2 B lymphocytes displayed dramatic changes in the expression of CD21 and CD23 surface markers. CD23 expression was downregulated, whereas the level of CD21 increased ( Figure 2C ). As a result, production of CD21 Figure 5B ). MZ B cells normally express high surface levels of the CD1d antigen, which is believed to participate in the presentation of lipid antigens to natural killer T cells. 17 In agreement with such observations, we found a significant increase Results are shown as means 6 SD and are representative of at least 3 independent experiments. P values were calculated using Student t test. *P # .05; **P # .01; ***P # .001; ****P # .0001. B, B-cell follicle; ns, not significant; T, T-cell zone.
in the number of B220
hi cells in the KO spleen (supplemental Figure 2C ). Expansion of the MZ-like B-cell population in miR-142 2/2 mice was further confirmed by immunohistochemical analysis of spleen sections stained with anti-IgM and anti-mucosal vascular addressin cell adhesion molecule 1 (MAdCam1) antibodies (supplemental Figure 2D ). We formally measured the areas of MZ and FO B-cell regions in WT and miR-142 2/2 lymphoid follicles.
In KO mice, we observed that the average MZ size increased ;2.4-fold, whereas the average FO zone area contracted (supplemental Figure shown as means 6 SD and are representative of 2 independent experiments. P values were calculated using either uncorrected Fisher's least significant difference test or Student t test. ns, not significant; **P # .01; ***P # .001; ****P # .0001. NF, newly formed. LNs (supplemental Figure 2N ,O). Taken together, our findings indicate that miR-142 negatively regulates B2 B-cell differentiation and output.
miR-142 deletion reduces T-cell abundance in the periphery
In contrast to B-cell accumulation, our analysis of miR-142
splenocytes revealed a strong reduction in the number of CD3 Overall, because of the expanding B-cell compartment and declining T-cell numbers, the B-to T-cell ratio in KO spleens was strongly skewed toward B cells ( Figure 2K-L) . For each T lymphocyte in the KO spleen, we observed ;5 B cells, whereas the WT mice displayed an almost 1-to-1 ratio ( Figure 2L ). In agreement with these results, immunohistochemical analysis of the KO spleen sections stained with anti-B220 and anti-CD3 antibodies revealed a sharply diminished T-cell zone and marked enlargement of the B-cell area in lymphoid follicles ( Figure 2M and supplemental Figure 2F ). Moreover, the B-cell zone in KO spleens lost its normal compact organization and became highly disorganized in shape. The presence of multiple B cell defects in miR-142 2/2 mice prompted us to examine the steady-state level of antibody production in these animals. Surprisingly, despite a significant expansion of the B-cell compartment, we found a strong decrease in the levels of all tested serum immunoglobulins in unimmunized miR-142 2/2 mice ( Figure 4A ).
In addition, the ability of miR-142 2/2 B cells to differentiate in vitro To further explore the consequences of miR-142 deletion on humoral immunity, we immunized mice with a T-cell-dependent (TD) antigen (2,4,6-trinitrophenyl conjugated to keyhole limpet hemocyanin [TNP-KLH]) and analyzed production of antigen-specific antibodies postimmunization. We found that in contrast to a robust immune response to the TNP-KLH challenge in the control mice, the antibody response in the KO mice was largely blunted ( Figure 5A ). Staining of spleen sections from TNP-KLH immunized mice with peanut agglutinin (PNA) revealed a lack of germinal centers in the KO organs and abnormal accumulation of PNA 1 myeloid cells in the tissue ( Figure 5B ).
Challenge of miR-142 2/2 mice with a T-cell-independent (TI) antigen (TNP-Ficoll) also resulted in a largely unproductive humoral immune response ( Figure 5C ). Since TI antigens typically do not require T cell help for B cell activation, our findings strongly imply that aberrant antibody production in the miR-142 2/2 mice is the result of a B-cell-specific defect. Finally, to examine the role of miR-142 in cellular immunity, we infected the KO mice with herpes simplex virus (HSV-1) and monitored their survival over time. C57BL/6 mice are normally resistant to ocular HSV-1 infection and depend on a robust T cell response to the virus for protection. [19] [20] [21] [22] However, miR-142 2/2 mice were highly susceptible to infection with HSV-1 and died of virus-induced encephalitis within 11 days ( Figure 5D ). Lowering the titer of HSV-1 by ;30-fold did not improve the survival of miR-142 2/2 mice. Together, our results suggest that miR-142 2/2 mice develop a combined immunodeficiency and as a result are unable to mount productive immune responses to both soluble and viral antigens.
Deletion of miR-142 results in global derepression of miR-142-3p targets
We investigated further how miR-142 deletion can lead to the multiple B cell defects observed in our mutant mice. To this end, we performed for the comparison of WT and KO curves were identical for both HSV-1 doses and were calculated using a log-rank (Mantel-Cox) test. Results are shown as means 6 SD. P values were calculated using Student t test. *P # .05; **P # .01; ***P # .001; ****P # .0001. Ag, antigen; ND, not detected. Figure 6A ). SylArray computes enrichment scores for miRNA seed sequences in the 39 untranslated regions (UTRs) of differentially expressed genes; thus, it can reveal the impact of a specific miRNA gene deletion on the cell transcriptome. Our findings suggest that changes in B-cell physiology in miR-142 2/2 mice are most likely the result of abrogation of miR-142-3p expression, whereas miR-142-5p has little contribution to the control of gene expression. This conclusion is in agreement with the significantly lower expression of mature miR-142-5p compared with mature miR-142-3p levels in several B-cell subsets ( Figure 6B ). Scrutiny of the list containing the most upregulated transcripts in miR-142 2/2 B cells revealed a number of genes with putative miR142-3p binding sites that have well-characterized roles in B-cell development and function (Table 1 ). In agreement with the notion that miRNAs can fine-tune cellular responses by targeting signaling nodes, 24 some of the putative miR-142-3p target genes found to be derepressed in the KO B cells could be arranged into signaling networks. For example, miR-142 2/2 B cells display simultaneous upregulation of Wiskott-Aldrich syndrome-like (WASL), cofilin 2 (CFL2), actin filament associated protein 1 (AFAP1), destrin (DSTN), and ras homolog family member Q (RHOQ) genes, all of which function in the actin cytoskeleton remodeling pathway (Table 1) . Moreover, recombination activating gene 1 (RAG1), RAG2, and terminal deoxynucleotidyltransferase (DNTT) play key roles in the generation of antigen receptor diversity through VDJ recombination, and all were found among the genes upregulated in miR-142 2/2 cells. The third signaling circuit that was also highly represented among the derepressed genes was the BAFF-R pathway, which includes BAFF-R, tumor necrosis factor receptor-associated factor 3 (TRAF3), and p52/p100 nuclear factor kB (NF-kB) subunit (NFKB2). , and WASL as direct miR-142-3p targets by 39 UTR luciferase reporter assay. Relative expression of WT and mutated BAFF-R, RAG1, and WASL 39 UTR reporter constructs upon cotransfection with either miR-142 expressing plasmid or empty control vector. Results are shown as means 6 SD and are representative of at least 2 independent experiments. P values were calculated using 2-way analysis of variance. **P # .01; ***P # .001; ****P # .0001.
We employed 39 UTR luciferase reporter assays to validate BAFF-R, RAG1 and WASL as miR-142-3p direct targets. According to TargetScan 25, 26 analysis, the 39 UTR of mouse BAFF-R gene contains 1 conserved miR-142-3p binding site, whereas the 39 UTR of mouse WASL has 2 conserved and 2 nonconserved sites ( Figure 6C ). The single binding site in the mouse RAG1 39 UTR is not evolutionary conserved ( Figure 6C ) but can still be bound by miR-142-3p in other species if nonstandard Watson-Crick base pairing is taken into account (supplemental Figure 4) . We cloned the 39 UTRs of WASL, RAG1, and BAFF-R genes downstream of a luciferase reporter and cotransfected them together with a miR-142 expression vector in 293T cells. Expression of all 3 reporter genes significantly decreased in the presence of miR-142, but not after transfection with a control vector ( Figure 6D ). Introduction of mutations into the predicted binding sites in the 39 UTRs of BAFF-R, RAG1, and WASL interfered with the ability of miR-142 to downregulate reporter expression, suggesting that miR-142-3p binds directly to these sites ( Figure 6D ). Because BAFF-R functions as a direct target of miR-142-3p, we decided to test the notion that dysregulation of this gene contributes to the development of B-cell defects in miR-142 2/2 mice. We focused on BAFF-R because of its well-established role in the control of peripheral B-cell growth and survival. 27, 28 BAFF-R is a member of the tumor necrosis factor receptor superfamily that exerts its functions by triggering activation of the noncanonical NF-kB signaling pathway 29 and the Akt kinase cascade. 30 Analysis of BAFF-R expression on the surface of miR-142 2/2 B cells by flow cytometry revealed a significant induction of BAFF-R levels ( Figure 7A-B) . Stimulation of purified WT B cells with BAFF ligand in vitro resulted in processing of the p100/NFKB2 precursor and subsequent accumulation of the p52 NF-kB subunit ( Figure 7C ). In contrast, miR-142 2/2 B cells displayed constitutive activation of the alternative NF-kB pathway ( Figure 7C ). Moreover, activation of the prosurvival Akt pathway was also altered in miR-142 2/2 B cells. Phosphorylated Akt protein was readily detectable in unstimulated cells, and the phosphorylation level was further elevated in response to BAFF ligand. To test how these signaling changes affect miR-142 2/2 B-cell functions, we examined proliferative responses of WT and KO B cells. We found that unstimulated miR-142 2/2 B cells proliferated at a rate similar to BAFF-activated WT cells, whereas stimulation with BAFF ligand strongly augmented their proliferative capacity ( Figure 7D ).
Lowering the BAFF-R gene dosage rescues the B-cell expansion defect in miR-142 2/2 mice Because miR-142 2/2 B cells express more BAFF-R, we reasoned that lowering the BAFF-R gene dose would allow us to dissect the functional role of a miR-142-3p-BAFF-R interaction in vivo. To this end, we crossed miR-142 2/2 mice with the A/WySnJ strain that carries a naturally occurring B-cell maturation defect-1 (BCMD-1) mutation. BCMD-1 is a loss-of-function mutation that results from a retrotransposon insertion into exon 3 of the BAFF-R gene, encoding the cytoplasmic domain of BAFF-R. 31, 32 The resulting miR-142 mice ( Figure 7K and data not shown). Taken together, our findings suggest that miR-142-3p-BAFF-R regulatory axis controls the size of the B2 B-cell compartment, whereas other miR-142-3p targets are probably mediating its effects on humoral immunity and B1 B-cell differentiation. 
Discussion
With a relatively simple mechanism of target recognition, miRNAs have the potential for high evolutionary plasticity, making them ideal regulators of innate and adaptive immunity in organisms continually presented with new pathogenic challenges. 33 The preferential and abundant expression of miR-142 in hematopoietic tissue led us to test the hypothesis that it controls certain aspects of immune homeostasis and function.
Our findings in miR-142 2/2 mice implicate this miRNA as a critical regulator of lymphopoiesis. The KO mice display an enlarged splenic B-cell compartment, mostly due to abnormal expansion of MZ-like B cells, as well as contraction of T-and B1 B-cell populations in the periphery. miR-142 plays a cell-intrinsic role in the regulation of lymphocyte differentiation because chimeric mice reconstituted with miR-142 2/2 BM develop the same B-and T-cell defects as the miR-142 KO animals. Although the role of miR-142 in lymphocyte development was not a subject of intense research in the past, our observations agree well with prior studies. For example, ectopic expression of miR-142 in BM progenitor cells was shown to hinder B-cell development in vitro. 7 Furthermore, conditional deletion of Dicer in B cells resulted in preferential expansion of MZ B cells, 3 whereas abrogation of Dicer expression in CD4 1 cells has been shown to reduce the cellularity of the peripheral T-cell compartment. 5 These results, taken together with the abundance of miR-142 expression in immune cells, make it a prime candidate for a miRNA gene whose deletion is driving the abovementioned immune defects in the Dicer-deficient mice.
Our results indicate that miR-142 is not only required for normal development of lymphocytes but also indispensable for the optimal P values were calculated using Student t test or 2-way analysis of. *P # .05; **P # .01; ***P # .001; ****P # .0001. ns, not significant.
function of mature B and T cells. We report herein that miR-142 B-cell defects in miR-142 2/2 mice seem to be driven mainly by the loss of miR-142-3p activity, whereas the absence of miR-142-5p expression has little impact. Two pieces of evidence support this notion, including the global derepression of miR-142-3p and not miR-142-5p target genes in miR-142 2/2 B cells, as well as the higher abundance of miR-142-3p compared with miR-142-5p in immune cells. Our conclusion is in agreement with observations by others that miR-142-3p and not miR-142-5p is responsible for the regulation of immune cell function in mice 12, 13, 35 and zebrafish. [9] [10] [11] Growing evidence suggests that miRNAs tightly control cellular responses and organismal homeostasis by targeting signaling nodes in a variety of physiological networks. In agreement with this notion, our study shows that miR-142-3p targets several signaling pathways that play well-established roles in B-cell differentiation and function, including the VDJ recombination complex, actin cytoskeleton rearrangement networks, and BAFF-R signaling cascade. We became particularly interested in the latter pathway because of its proven role in B-cell homeostasis. We provided genetic evidence that the miR-142-3p-BAFF-R axis controls the size of the B2 B-cell compartment, especially the MZ B-cell subset. Loss of miR-142-3p expression elevates the level of BAFF-R on the surface of B cells and results in constitutive activation of the downstream signaling. Consequently, miR-142 2/2 mice display dramatic changes in B-cell homeostasis, which to a large degree resemble defects observed in BAFF transgenic mice, including splenomegaly, expansion of the B-cell compartment, and increases in MZ B cells. 36 However, not all B-cell phenotypes, such as the B1 B-cell defect and hypogammaglobulinemia, were rescued in miR-142 2/2 mice by lowering the BAFF-R gene dose. These results imply separation of function at the level of miR-142-3p targets and, therefore, highlight the relevance and need for future analysis of other targets of this miRNA in B-cell differentiation and function. Although our work reveals novel insights into miR-142 function, one clinical implication of this study is a rational possibility that mutations in miR-142 gene are behind compromised immunity in patients with immunodeficiencies. Primary immunodeficiency diseases are monogenic disorders that are usually manifested by a wide range of clinical symptoms including persistent infections, autoimmunity, lymphoproliferation, and cancer. 37 Intriguingly, miR-142 mutations are found in ;20% of diffuse large B-cell lymphoma patients. 38 Experimental testing of our hypothesis that miR-142 lesions are important etiologic factors for primary immunodeficiency diseases could potentially pave the way for the development of novel diagnostic and pharmacologic strategies to restore immune homeostasis in these patients.
